VelosBio: Why Merck (MRK) Is Buying VelosBio For $2.75 Billion In Cash

Merck (NYSE: MRK) - known as MSD outside the US and Canada - announced recently that it entered into a definitive agreement pursuant to which Merck (through a subsidiary) will buy all of the outstanding shares of VelosBio for $2.75 billion in cash. The post Why Merck (MRK) Is Buying VelosBio For $2.75 Billion In Cash appeared first on Pulse 2.0.